Please assess the completion status of the following clinical trial:

Trial Title: Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Male or female patient is at least 2 years of age;~2. Patient is in general good health;~3. Patient has partial thickness burn that crosses at least one peripheral joint axial to the proximal interphalangeal joints;~4. Patient has one unburned contralateral joint without major internal or external joint derangement to be used as control~5. Patient is willing and able to cooperate with the protocol for 30 days~6. Patient is capable of provided informed consent~7. Patient provides authorization for use and disclosure of protected health information~Exclusion Criteria:~1. Age less than 2 years;~2. Patient has superficial or full thickness burn wounds;~3. Patient has acutely infected wounds;~4. Patient has wounds with surrounding cellulites;~5. Patient has a history of hypersensitivity to any components of either the nanoparticle or sodium hydrocellulose dressing, or any know sensitivities to other hydrogel bandage treatments~6. Patient has a concurrent clinical condition, which in the judgment of the Investigator cold either pose a health risk to the patient while participating in this study, or could potentially influence the outcome of the study;~7. Patient is wearing any type of orthopedic device that may come in contact with the dressing;~8. Patient has history of poor wound healing, history of smoking, history of drug/alcohol abuse, any other skin/immune system condition that would increase likelihood of wound irritation, infection or increase chance of early termination~9. Patient has wound originating from chronic condition~10. Patients with history of any immunodeficiency syndrome or condition~11. Patients who have applied any dressing or medication (OTC or prescription) to the wound (within 48 hours of study? )~12. Patient has participated in a clinical research study within the last 30 days prior to enrollment;~13. Patient is unable to communicate or to cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Altrazeal Flexible Hydrogel Nanoparticle Wound Dressing (Type: EXPERIMENTAL): Nanoflex Powder Dressing applied to joint
- Aquacel AG, typical carboxymethylcellulose dressing (Type: ACTIVE_COMPARATOR): Sodium CMC dressing control applied to joint

Based on this trial design, predict the completion outcome and termination type (if applicable).